Search Results - "Sandberg, Dan"
-
1
Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma
Published in American journal of roentgenology (1976) (01-11-2012)“…The purpose of this study was to evaluate the accuracy of whole-body diffusion-weighted MRI (DWI) and (18)F-NaF PET/CT for detection of bone metastases in…”
Get full text
Journal Article -
2
Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT
Published in Theranostics (2016)“…Positron Emission Tomography (PET) imaging of HER2 expression could potentially be used to select patients for HER2-targed therapy, predict response based on…”
Get full text
Journal Article -
3
Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT
Published in European journal of nuclear medicine and molecular imaging (01-08-2017)“…Purpose In phase I/II-studies radiolabelled ABY-025 Affibody molecules identified human epidermal growth factor receptor 2 (HER2) expression in breast cancer…”
Get full text
Journal Article -
4
Whole-Body Diffusion-Weighted MRI Compared With 18 F-NaF PET/CT for Detection of Bone Metastases in Patients With High-Risk Prostate Carcinoma
Published in American journal of roentgenology (1976) (01-11-2012)“…OBJECTIVE: The purpose of this study was to evaluate the accuracy of whole-body diffusion-weighted MRI (DWI) and 18 F-NaF PET/CT for detection of bone…”
Get full text
Journal Article -
5
First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the 111 In-ABY-025 Affibody Molecule
Published in Journal of Nuclear Medicine (01-05-2014)“…The expression status of human epidermal growth factor receptor type 2 (HER2) predicts the response of HER2-targeted therapy in breast cancer. ABY-025 is a…”
Get full text
Journal Article -
6
Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule Ga-68-ABY-025 in Breast Cancer Patients
Published in The Journal of nuclear medicine (1978) (01-06-2016)“…Ga-68-ABY-025 is a radiolabeled Affibody molecule for in vivo diagnosis of human epidermal growth factor receptor 2 (HER2)-positive breast cancer tumors with…”
Get full text
Journal Article -
7
Home Oxygen Program review: Regionalization in Vancouver Coastal Health and British Columbia
Published in Canadian journal of respiratory therapy : CJRT = Revue canadienne de la thérapie respiratoire : RCTR (2015)“…Since its inception in the 1980s, the Home Oxygen Program in British Columbia was centrally managed by the Ministry of Health. Initially a small program with…”
Get full text
Journal Article -
8
Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68 Ga-ABY-025 in Breast Cancer Patients
Published in Journal of Nuclear Medicine (01-06-2016)Get full text
Journal Article -
9
Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule ^sup 68^Ga-ABY-025 in Breast Cancer Patients
Published in The Journal of nuclear medicine (1978) (01-06-2016)“…^sup 68^Ga-ABY-025 is a radiolabeled Affibody molecule for in vivo diagnosis of human epidermal growth factor receptor 2 (HER2)-positive breast cancer tumors…”
Get full text
Journal Article -
10
Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule super( 68)Ga-ABY-025 in Breast Cancer Patients
Published in The Journal of nuclear medicine (1978) (01-06-2016)“…super( 68)Ga-ABY-025 is a radiolabeled Affibody molecule for in vivo diagnosis of human epidermal growth factor receptor 2 (HER2)-positive breast cancer tumors…”
Get full text
Journal Article -
11
Accuracy of [Ga-68]ABY-025 PET/CT for determination of HER2-expression in metastatic breast cancer
Published in The Journal of nuclear medicine (1978) (2015)Get full text
Journal Article -
12
Non-invasive determination of HER2-expression in metastatic breast cancer by using 68 Ga-ABY025 PET/CT
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
13
Non-invasive determination of HER2-expression in metastatic breast cancer by using Ga-68-ABY025 PET/CT
Published in Journal of clinical oncology (2015)Get full text
Journal Article -
14
First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the ^sup 111^In-ABY-025 Affibody Molecule
Published in The Journal of nuclear medicine (1978) (01-05-2014)“…The expression status of human epidermal growth factor receptor type 2 (HER2) predicts the response of HER2-targeted therapy in breast cancer. ABY-025 is a…”
Get full text
Journal Article -
15
First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the sigma up 111 member of n-ABY-025 Affibody Molecule
Published in The Journal of nuclear medicine (1978) (01-05-2014)“…The expression status of human epidermal growth factor receptor type 2 (HER2) predicts the response of HER2-targeted therapy in breast cancer. ABY-025 is a…”
Get full text
Journal Article -
16
Whole-Body Diffusion-Weighted MRI Compared With 18F-NaF PET/CT for Detection of Bone Metastases in Patients With High-Risk Prostate Carcinoma
Published in American journal of roentgenology (1976) (01-11-2012)“…OBJECTIVE. The purpose of this study was to evaluate the accuracy of whole-body diffusion-weighted MRI (DWI) and 18F-NaF PET/CT for detection of bone…”
Get full text
Journal Article -
17
Developing Student Leaders in Campus Outdoor Recreation Programs: An Appreciative Inquiry
Published in Journal of outdoor recreation, education, and leadership (22-03-2017)“…Campus outdoor recreation programs can play an integral role in developing student leaders. In this study, we sought a better understanding of the shared…”
Get more information
Journal Article -
18
Measuring HER2-expression in metastatic breast cancer using 68Ga-ABY025 PET/CT
Published in European journal of nuclear medicine and molecular imaging (2014)Get full text
Journal Article -
19
-
20